Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.

Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol. 2008 Nov 11; 52(20):1640-8.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Benzazepines
Double-Blind Method
Female
Heart Failure
Hospitalization
Humans
Internationality
Kaplan-Meier Estimate
Male
Middle Aged
Myocardial Revascularization
Pacemaker, Artificial
Prospective Studies
Vasopressins

authors with profiles

John Edward A. Blair